Read the latest news from the MassBio community! This space is for members to share company updates and press releases. Members may not post stories that are copyrighted by news publications or post sales pitches.
Asymmetrex’s AlphaSTEM Test™ for specific counting of tissue stem cells is rapidly gaining greater interest. Scientist.com’s new newsletter, INNOV8, featured it for applications in drug development. Read More
CN Bio Innovations Limited announces a research collaboration with global biopharmaceutical company AstraZeneca to validate a new in vitro research tool that enables the high throughput evaluation of Read More
MA stem cell biotech company Asymmetrex proposes that its new technology for certifying the specific dose and quality of tissue stem cells used in experimental treatments would improve FDA’s efforts. Read More
Since 2001, Colpitts Clinical has partnered with GlobalStar Travel Management and over 85 enterprises to create a global network of multinational travel solutions available in more than 70 countries. Read More
Asymmetrex introduces the first stem cell-specific quality control test to suppliers at the 6th Annual Clinical Trial Supply New England 2017 in Boston. Read More